Smart Olfaction App to Reduce Relapse
ConditionNicotine Dependence
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Houston
About this trial
The proposed project aims to refine and test a novel biobehavioral smoking cessation intervention that integrates the strategic application of olfactory stimulation to reduce cigarette craving with an established smartphone-based smoking cessation application. The specific aims of this study are: (1) refine the design and methodology of our olfactory stimulation delivery system (OSDS) and (2) compare, in a pilot randomized controlled trial (RCT), the effects of a smartphone based app for smoking cessation (Smart-T) with and without the OSDS on smoking cessation outcomes.
Eligibility criteria
Qualifiers
At least 18 years of age
Ability to read, understand and speak English
Currently smoke at least 5 cigarettes daily for one year or longer
Do not currently smoke marijuana or currently smoke marijuana but willing to not smoke during the duration of the study
Disqualifiers
Olfactory dysfunction including inability to smell, a very weak or distorted sense of smell, or sensitivity to odors
Report any allergies or negative reactions to odors/fragranced products
Being pregnant, breastfeeding, or planning to become pregnant within the next month
Report hypertension that is not under control
Trial design
Treatments tested in this trial
- Ad Libitum Use followed by Instructed Use of the Inspire Device
- Instructed Use followed by Ad Libitum Use of the Inspire Device
- Smart-T Smoking Cessation App with the Inspire Device Condition
- Smart-T Smoking Cessation App Without the Inspire Device Condition
- Nicotine replacement therapy (NRT)
- Inspire Device
Treatment groups
132 Participants
are divided into 4 treatment groupsSponsors and collaborators
University of Houston
Lead sponsor
University of Pittsburgh
Collaborator
University of Oklahoma
Collaborator
Brown University
Collaborator
Source ClinicalTrials.gov